Literature DB >> 32723779

Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity.

Ravi Masson1, Hooman Bakhshi2, Tariq M Haddad2,3.   

Abstract

A 70-year-old woman with HER2+/ER+ breast cancer on adjuvant trastuzumab therapy without a history of cardiovascular disease presented with respiratory failure from influenza and was found to have intermittent left bundle branch block (LBBB) with new onset systolic heart failure. Her course was complicated by polymorphic ventricular tachycardia and recurrent chest pain. Significant investigations included a normal cardiac MRI and cardiac catheterisation with unobstructed coronaries. It was determined that the aetiology of her heart failure was trastuzumab-induced cardiotoxicity after comprehensive workup. This case highlights an uncommon presentation of LBBB and the steps taken to diagnose a rare cardiomyopathy. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  breast cancer; cancer - see oncology; chemotherapy; heart failure; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2020        PMID: 32723779      PMCID: PMC7389772          DOI: 10.1136/bcr-2020-236009

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  TRANSIENT BUNDLE-BRANCH BLOCK.

Authors:  G E BAUER
Journal:  Circulation       Date:  1964-05       Impact factor: 29.690

2.  Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort.

Authors:  Etienne Huvelle; Renaud Fay; François Alla; Alain Cohen Solal; Alexandre Mebazaa; Faiez Zannad
Journal:  Eur J Heart Fail       Date:  2009-12-21       Impact factor: 15.534

3.  Bundle branch block patterns, age, renal dysfunction, and heart failure mortality.

Authors:  Peter A McCullough; Sohail A Hassan; Vinay Pallekonda; Keisha R Sandberg; David B Nori; Sandeep S Soman; Sonali Bhatt; Michael P Hudson; W Douglas Weaver
Journal:  Int J Cardiol       Date:  2005-07-10       Impact factor: 4.164

4.  Left Bundle Branch Block in Acute Cardiac Events: Insights From a 23-Year Registry.

Authors:  Fahad Alkindi; Ayman El-Menyar; Jassim Al-Suwaidi; Ashfaq Patel; Abdurrazzak A Gehani; Rajvir Singh; Hajar Albinali; Abdulrahman Arabi
Journal:  Angiology       Date:  2014-12-03       Impact factor: 3.619

5.  The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

Authors:  Glen Sumner; Omid Salehian; Qilong Yi; Jeff Healey; James Mathew; Khalid Al-Merri; Khaled Al-Nemer; J F E Mann; Gilles Dagenais; Eva Lonn
Journal:  J Cardiovasc Electrophysiol       Date:  2009-02-27

6.  Left Bundle Branch Block: Current and Future Perspectives.

Authors:  Nicholas Y Tan; Chance M Witt; Jae K Oh; Yong-Mei Cha
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-18

Review 7.  Episodic Left Bundle Branch Block-A Comprehensive Review of the Literature.

Authors:  George Bazoukis; Konstantinos Tsimos; Panagiotis Korantzopoulos
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03       Impact factor: 1.468

Review 8.  Trastuzumab (Herceptin)-associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review.

Authors:  Chung-Ming Tu; Kai-Ming Chu; Shin-Ping Yang; Shu-Mung Cheng; Wen-Been Wang
Journal:  Am J Emerg Med       Date:  2009-09       Impact factor: 2.469

Review 9.  Left bundle branch block: Epidemiology, etiology, anatomic features, electrovectorcardiography, and classification proposal.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Marianne P C de Rezende Barbosa; Rodrigo Daminello-Raimundo; Luiz C de Abreu; Kjell Nikus
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-22       Impact factor: 1.468

10.  Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer.

Authors:  Somaira Nowsheen; Paul V Viscuse; Ciara C O'Sullivan; Nicole P Sandhu; Tufia C Haddad; Anne Blaes; Jennifer Klemp; Lara Nhola; Joerg Herrmann; Kathryn J Ruddy
Journal:  Curr Breast Cancer Rep       Date:  2017-07-14
View more
  1 in total

1.  Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.

Authors:  Diego Macías Saint-Gerons; Rafael Tabarés-Seisdedos
Journal:  Eur J Clin Pharmacol       Date:  2021-05-03       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.